News Releases
Thursday, March 24, 2011
Data From Clinical Trial Evaluating Cardiovascular Systems' Diamondback 360° to Treat Above-the-Knee Peripheral Arterial Disease to Be Presented at ACC
Thursday, March 17, 2011
Cardiovascular Systems Receives FDA 510(k) Marketing Clearance for Stealth 360°(TM) Orbital PAD System
Thursday, February 24, 2011
Cardiovascular Systems to Present at Upcoming Investor Conferences
Thursday, February 10, 2011
Cardiovascular Systems Files Special 510(k) for Stealth 360°(TM) Orbital Pad System
Wednesday, February 2, 2011
Cardiovascular Systems Reports Fiscal 2011 Second-Quarter Financial Results
Wednesday, January 26, 2011
Cardiovascular Systems to Webcast Fiscal 2011 Second-Quarter Earnings Conference Call Wednesday, February 2
Fact Sheets
- Orbital Mechanism of Action (PDF)
- Peripheral Arterial Disease (PDF)
- 360° Clinical Series — (Clinical Trials FS) (PDF)
- Lower-Limb Amputation (PDF)
- Glossary (PDF)
